IRLAB Therapeutics AB (publ)

Research IRLAB Therapeutics AB (publ) (IRLAB-A) on Bullrun: market cap SEK 255.49M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerIRLAB-A
ExchangeST
CountrySweden
SectorHealthcare
IndustryBiotechnology
CurrencySEK
Market capSEK 255.49M
Financial periodQ1 2026
RevenueSEK 39.36M
Net incomeSEK 9.12M
Free cash flow-SEK 28.68M

Valuation Snapshot

latest market cap is SEK 255.49M.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	n/a	n/a	n/a	n/a	-1.76	SEK 81.86M	SEK 29.95M	SEK 30.72M
FY2024	SEK 94.63M	-SEK 83.13M	-SEK 65.79M	n/a	-1.6	SEK 66.92M	SEK 0	SEK 32.64M
FY2023	SEK 5.68M	-SEK 177.84M	-SEK 165.14M	n/a	-3.43	SEK 111.31M	SEK 24.51M	SEK 115.76M
FY2022	SEK 61.14M	-SEK 113.41M	-SEK 145.49M	n/a	-2.19	SEK 252.78M	SEK 0	SEK 290.83M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-24	SEK 255.49M	n/a	n/a	n/a

About IRLAB Therapeutics AB (publ)

IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson's disease and other central nervous system (CNS) disorders in the United States. The company develops Mesdopetam (IRL790), which has completed both a Phase IIb clinical trial for the treatment of levodopa-induced dyskinesias, and a Phase I clinical trial for the treatment of Parkinson's disease psychosis;

Related stock research

Sweden stocks Sweden Healthcare stocks A-Z stock index

Other Healthcare stocks

Camurus AB (0RD1) Flerie AB (publ) (1NP1) GENOVIS AB SE-40 (5GV) Fluicell AB (publ) (5J90) ExpreS2ion Biotech Holding AB (publ) (5JD0) ALZINOVA AB (78D) 7AL0 (7AL0) ASCELIA PHARMA AB (7ZA) Biosergen AB (8N10) ABERA BIOSCIENCE AB (8WK) Ascelia Pharma AB (publ) (ACE) AcouSort AB (ACOU)

Frequently asked questions

What is IRLAB Therapeutics AB (publ)'s market cap?

IRLAB Therapeutics AB (publ)'s market capitalization is SEK 255.49M.

What does IRLAB Therapeutics AB (publ) do?

IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson's disease and other central nervous system (CNS) disorders in the United States.